foxo4 dri peptide senolytic 2023 FOXO4-DRI FOXO4/p53 – Peptagon FOXO4-DRI induces keloid senescent fibroblast
Description
Supports healthy circulation and blood vessels*
Type 2 diabetes: sensitization, not just weight Diabetes trials measure a different baseline and endpoint than obesity trials
Primary outcome is PFS
That approval doesn't just mean "this is good for wellness"it's for a very specific context
